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ABSTRACT
We report here the localisation of sequences responsible for the faulty expression of
human ,B-globin gene in Putko and K562 cells. Complete fl-globin gene introduced into
these cells produces transcripts with abnormal 5' ends, while cotransfected mouse H2 gene
is expressed correctly. Using hybrid constructs of these two genes we demonstrate that
aberrant activity is conferred by sequences 5' of the fl-globin gene. Thus P-globin promoter
attached to the H2 coding sequence produces H2 transcripts with truncated 5' ends. By
introducing a series of deletions in the /-globin promoter we restrict these sequences to
the -77 / +28 base pair region spanning the CAAT element to the translation initiation
site. These results are consistent with the lack of recognition of the fl-globin gene major
cap site in Putko and K562 cells. We suggest that inactivity of the adult globin gene in the
embryonic/fetal environment is at least in part conferred by sequences within the fl-globin
gene promoter.
INTRODUCTION
Globin genes become activated in the later stages of erythroid differentiation during
transition of the proerythroblast to erythroblast. In humans three different types of fl-like
genes (e, -y, ,) are clustered together in the short arm of chromosome 11 in the sequencial
order of their activation (for review see 1). Regulation of expression of these genes is
largely determined by interaction of transacting factors with sequences within or flanking
the genes (2,3,4,5,6,7).
Introduction of cloned ,B-globin gene into mammalian cell lines has revealed three dis-
tinct upstream sequences required for efficient transcription from the cap site of this gene:
the ATA, CCAAT and CCA/TCACCCT elements located at -30, -75 and -90 base pairs
from the mRNA capping site (8). These sequences which are responsible for constitutive
expression are also present in the promoters of the embryonic and foetal globin genes. The
mouse erythroleukemic cell line (MEL)(9) has been used as a model system to investigate
developmental specific regulation of the adult globin gene expression. Studies with cloned
hybrid human genes in this system have identified at least two additional controlling ele-
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ments. One is located 5' to the gene and the other downstream from the mRNA capping
site. It has been suggested that negative or positive interaction of tranrs-acting factors
with these elements is responsible for the developmental regulation of the P-globin gene.
Interestingly the upstream element responds to induction when attached 5' to the mouse
H2 gene but not when 5' to the human a-globin gene (10,11). B
A complementary system to the MEL cells is provided by the K562 cell line and
its derivatives Putko and Sutko (13). These lines in contrast to MEL cells express the
embryonic and foetal but not the adult globin genes (14,15, 16). We showed earlier that
the differential expression of the globin genes is regulated in trans in K562 cells. We
also showed that aberrant /3-globin transcripts can be detected in tranfected cells, but
were unable to define the 5' end and therefore the origin of these transcripts (17). Other
independant studies have reported complete absence of ,-globin transcripts in K562 cells
transfected with cloned ,B-globin genes (18). We report here that 09-globin transcripts in
Putko cells have shorter 5' ends than expected. Using hybrid constructs with the mouse H2
gene attached to the human /9-globin promoter we show that upstream regulatory elements
are responsible for the abnormal transcription. Sequential truncation of the upstream /9-
globin sequences limited these sequences to a region of 77 base pairs overlapping the
constitutive promoter.
MATERIALS AND METHODS
Transfection of cells
Putko cells (13) were maintained in RPMI medium supplemented by 10% fetal calf
serum. Cells were transfected with electroporation. 1o0 cells were resuspended in 0.5 ml
PBS together with 25 pg DNA tagged with AGPT gene which confers resistance to the
antibiotic G418. The mixture was placed in a Sarsted disposable cuvette 0.5x1.0 cm, which
had been adapted with two 1.0 cm aluminium electrodes. The cells were subjected two
electric shocks at 2 KV, using an ISCO electrophoresis power supply (Model 494). Shocked
cells were kept at 4°C for 30 minutes and then plated out in the normal growth medium.
24 hours after transfection G418 selection was applied at concentrations of 500 pg/ml of
medium. Resistant cells were plated in soft agar (0.3%) in the same medium. Individual
clones were picked and grown further in the presence of G418.
K562 cells (12) were maintained in aMEM medium supplemented with 10% fetal calf
serum. Cells were transfected using CaP04 as described before (10). Individual G418
resistant clones were picked from 0.3% agar and grown further in the presence of G418.
Purification of RNA
107 cells were lysed with 1.0 ml 6M guanidium chloride and phenol extracted. Nucleic
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acid was ethanol precipitated, dissolved in 10 mM Tris (pH 7.5), 10 mM MgCl, 50 mM
NaCl, and treated with RNase-free DNase. RNA was finally phenol extracted and ethanol
precipitated.
For the preparation of poly A RNA, 107 cells were washed with PBS and resuspended
in 2.5 ml of 100 mM NaCl, 20 mM Tris-Cl (pH 7.4), and lOmM EDTA. Proteinase K was
added to 200 mg/nil, and SDS to 0.5%. The mixture was homogenised with a Sorvall
omnimixer at 3/4 full speed for 30 seconds. The solution was then incubated at 37°C for
20 minutes. 0.5 M NaCl and 50 mg oligo (dT) cellulose was added and the slurry was
shaken for 6 hours a room temperature. The oligo (dT) was washed with 100 mM NaCl,
10 mM Tris-Cl (pH 7.4), 1 mM EDTA and 0.2% SDS. Poly A RINA was eluted with 1 mM
Tris-Cl (pH 7.8), 1 mM EDTA and 0.2% SDS. 20 pg carrier yeast RNA was added and
the total was ethanol precipitated.
Northern blotting
Poly A RNA from 107 cells was resuspended in 2 mM MOPS (pH 7.0), 0.2 mM
EDTA, 0.5 mM NaAc, 50% Formamide, 7.4% Formaldehyde heated to 600 C for 5 minutes,
immediately chilled on ice and loaded onto a 0.7% agarose gel containing 20 mM MOPS
(pH 7.0), 1 mM EDTA, 5 mM NaAc and 2.2 M formaldehyde. Electrophoresis buffer was
of the same composition. After electrophoresis the RNA was blotted onto nitrocellulose
and hybridised with nick translated DNA probe.
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Figure 1: Structure of the human P-globin, mouse H2Kbml gene and hybrids of these two
genes. The construction of the hybrid genes was described in (10). Filled boxes represent
exons, and open boxes introns. Sizes in kb of the flanking genomic sequences and of the
genes are shown. a)P-globin gene b)H2Kbml gene c)H2fl hybrid gene d) Hfl2 hybrid gene.
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SI nuclease analypie
Levels of mRNA were measured by S1 muclease analysis as described before (10).
DNA probes were end-labeled using T4 polynucleotide kinase or reverse transcriptase to
a specific activity of greater than 107 cpm/pg. Labeled probe was hybridized to 10-50
pg samples of total cellular RNA in 30 p1 40 mM PIPES (pH 6.4), 400 mM NaCl, 1 mM
EDTA, and 80% recrystallized formamide for 8-12 hours. Hybridization temperature was
520C. After hybridization, samples were digested for 2 hours with 3000 units SI nuclease
(Boehringer) in 300 p1 200 mM Nacl, 30 mM NaAc (pH 4.8), 2 mM ZnSO4 at 20°C. SI
protected DNA was ethanol precipitated and electrophoresed on a 7 M urea 7% acrylamide
gel.
RESULTS
Human 9- globin gene introduced into Putko and K562 cells is expressed aberrantly.
We studied the expression of the human fl-globin gene introduced into Putko and
K562 cells. The former was a 3.1 kb HpaI-PstI fragment containing the entire human P
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Figure 2 SI nuclease protection analysis of human fl-globin aberrant transcripts in
transfected Putko cells.
a) Expanded clones of transfected Putico cells expressing ,8-globin were harvested in late
log phase of growth. Poly A RNA corresponding to 2x107 cells was analysed by SI nuclease
protection assay using the illustrated 3' end labelled probe. Lanes 1 and 2 are two isolates
of Putko cells expressing fl-globin. 0.1 ng of human sickle polyA RNA was used for positive
control (+). RNA from untransfected Putko cells was used for negative control (-). End
labeled PBR322 DNA predigested with Hinfl was used as molecular weight markers (M).
b) 40 pg total cellular Putko RNA was analysed by SI nuclease protection assay using the
illustrated 5' end labelled probe. Lanes 1 and 2 correspond to those in Figure 2a. Lanes
marked 3 and 4 correspond to RNA from Putko cells that contain transfected copies of fi-
globin gene but do not show any detectable expression with the 3' end labelled probe . 0.1
ng of human sickle polyA RNA was used for positive control (+). Lane (M) is molecular
weight markers. Arrows point to Si protected fragments resulting from the hybridization
of probe to the 5' end of control f-globin RNA and f transcripts in Putko or K562 cells.
The structure of an intron-less,8-globin gene used for the isolation of S1 probes is shown.
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globin gene together with 0.92 kb of 5' and 0.75 kb of 3' flanking sequences cloned in the
,BPTM plasmid (Fig la). This recombinant was cotransfected with the H2PTM plasmid
containing the mouse H2Kbml gene and approximately 2 kb flanking sequences on either
end of the gene (Fig lb). Both plasmids contained the AGPT gene linked to the TK
promoter (10,19) Stably transfected cells were selected by virtue of their resistance to the
antibiotic G418.
Expression of the #-globin gene was analysed by the SI nuclease protection assay. A 3'
labelled 700 bp EcoRI/MspI probe was used to protect 212 nucleotides at the 3' end of the
::.*
Figure~3: S1 nuclease analysis of mouse H2Kbml gene transcripts in transfected human
Putko or K562 cells.
a) Putko populations were cotransfected with cloned mouse H2Kbml gene and humanjP-globin gene. 10 pg samples of total cellular RNA from the transfected populations(lanes 1-5) were analysed by 51 nuclease protection assay using the 5' end labeled mouse
H2Kbml probe illustrated. 5 pg of total cellular R.NA from 16 day old 057 BL/10 mouse
embryos was used as positive control (+). 10 pg of RNA from untransfected Putko cells
was used for negative control (-). The arrow points to 51 protected fragments. Lane (M)
is molecular weight markers.
b) K562 cells were transfected with cloned mouse H2Kbml gene. 10 pg samples of total
cellular R.NA was analysed by 51 protection assay as above. RNA from untransfected
K562 cells was used for negative control (-). Positive control (+) and markers are as above.
Arrows point to 51 protected fragments resulting from self hybridization of input probe
and from hybridization of probe to the complementary 5' end of H2 RNA respectively.
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#-globin mRNA while the entire first and 10 bp of the second exons were detected by a 5'
labelled 520 bp AccI-AccI probe. Expression of the ,B-globin gene was detected in only two
from a total of twenty independently transfected G418 resistent Putko populations. These
were seeded in soft agar in order to obtain individual clones. Fig 2a shows 3' S1 analysis
of the fl-globin transcripts in the isolated clones. The level of ,B-globin mRNA in the
expressing Putko clones was 0.5-1 transcript per cell as compared to the human sickle cell
RNA control. Surprisingly clones from both the fi-globin expressing populations showed
5' protected fragments 30-40bp shorter than expected, suggesting abnormal initiation of
transcription (Fig 2b). Consistent with this were the results obtained using the 460bp
Rsal-BamHI probe which protected fragments shorter than the expected 340bp at the
5' of the f8-globin mRNA (results not shown). Southern blot analysis showed that both
expressing clones contained the intact 5' flanking and coding regions of the introduced
fl-globin gene (results not shown). In addition no ,B-globin transcripts were detected in 10
independent K562 populations transfected with the human ,B-globin gene.
In contrast to fB-globin the cotransfected mouse H2Kbml gene was normally expressed
in all the G418 resistant populations analysed. This was revealed by SI nuclease analysis
using a 5' labelled 156bp HhaI-HhaI probe, that produced an 89 bp protected fragment
(Fig 3). RNA from untransfected Putko or K562 cells does not protect this probe. The
H2 Kbml gene is a mouse class I major histocompatibility antigen and is expressed in a
non-tissue specific manner.
Our results suggest that the human ,6-globin gene promoter is inactive in Putko and
K562 cells. Low level expression of this gene in Putko cells is due to aberrant transcription
initiation events. The mouse H2Kbml gene is accurately transcribed in both cell lines.
Expression of hybrid genes containing the H2Kbml promoter and human f - globin
coding sequences in Putko and K562 cells.
In order to localize the sequences responsible for inactivity of the ,-globin gene, we
used hybrid constructs containing the H2Kbml promoter joined to the human fl-globin
coding and 3' flanking sequences (Fig lc) (10). This construct was stably introduced
in Putko and K562 cells by electroporation. Transcnrpts were analysed using a 280 bp
Aval-Aval 5' labelled probe. Two out of five Putko and four out of ten K562 transfected
populations expressed the H,f hybrid gene. Expression of this construct was accurate in
both Putko and K562 cells (Fig 4). Thus the ,-globin coding or 3' sequences are not
responsible for the observed aberrant transcription. This suggests that sequences 5' of the
,8-globin gene prevent normal initiation of transcription in these cells. Our results can
not eliminate the possible existence of independent down regulatory elements 3' of the /3
globin gene cap site that do not interfere with correct initiation of transcription.
7205
Nucleic Acids Research
--2 .: - :
ApP E £^ w
,_
B 36t.@S},..
344
.e s> 0 :Y£gffip:>Kl:i. .e_s .<) 4t) ge;;
w iP,$t 2<-':.>.
*!''. .: .' -3'
._!eEi
2 "^. iiil 1t s iFs- d
e , w r *eS.:a - .\: , .e
4.t' *:
:1B :.
||||
296 * !
220B_: ... .
1 54 _ .
A A..
Figure 4: Si nuclease protection analysis of hybrid mouse H2 human fi-globin gene
transcripts in transfected Putko or K562 cells.
a) Expanded clones of transfected Putko cells expressing Hf hybrid transcripts were har-
vested . 30 pg samples of total cellular RNA was analysed by SI nuclease protection assay
using the 5' end labeled probe illustrated. 0.1 ng of poly A human sickle RNA was used
as positive control (+). Only 120 bp of the probe is protected by the sickle RNA which
lacks the 5'H2 sequences. The expected protected fragment for normal H,B transcripts is
145 bp. Arrows point to the S1 protected fragments resulting from protection of the probe
by self hybridization or by hybridization to RNA respectively.
b) RNA from K562 populations transfected with hybrid Hfl gene was analysed by S1
nuclease protection assay. RNA from untransfected K562 cells was used for negative control
(-). Arrows point to input probe and the RNA protected probe fragment. The structure
of an H,B hybrid gene lacking the first intron, used for preparing SI probes is shown. The
diamond symbol shows the junction of the two genes.
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Figure 5: Structure of human ,B-globin mouse H2Kbml gene recombinants with trunca-
tions in the upstream sequences. Deletions within the 5' region of the human ,B-globin
gene promoter were as shown. Hhal restriction cuts producing a 1 kb 5' PH hybrid probe
are shown.
Aberrant transcription in Putko cells of gene hybrids containing ,8 - globin 5' and
H2Kbml 3' sequences.
Since expression of human P-globin in Putko cells directed by the H2 promoter is
accurate,sequences 5' of the ,B are likely to be responsible for aberrant transcription. To
examine this suggestion a construct containing the P-globin promoter attached to the
H2Kbml coding sequences was introduced into Putko and K562 cells. This chimeric gene
has been previously shown to be inducible in differentiating MEL cells (10). Additional
hybrids were made by sequencially deleting sequences down to -815, -295, or -77 bp of the
P-globin promoter (Fig 5).
Transcription of fiH mRNA was studied by S1 nuclease analysis using a 600 bp AvaIlI-
Aval internal probe which spans the junction between the third exon and intron of the
H2Kbm1 gene and normally detects a 230 bp protected fragment. Expression of fiH
transcripts was detected from all constructs used. The detection of PH mRNA was not
related to rearrangement or deletion of the introduced sequences upon integration into the
host chromosomes. On the other hand the presence of intact promoter did not always result
in expression of the hybrid gene. Intensities of S1 nuclease resistant bands were comparable
for the various deletions and varied by up to five fold in the populations carrying the same
deletion (Fig 6a).
Correct initiation of transcription was examined by S1 nuclease analysis using a lkb
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Figure 6: 51 nuclease analysis of human fi-globin mouse H2Kbml hybrid gene transcripts
in Putko cells transfected with truncated fi-globin promoter recombinants.
a) 10 pg samples of total cellular RNA from five Putko populations transfected with fiH
hybrid gene having only 77 bp of fi-globin promoter region (see Fig 5d) was analysed by
51 nuclease protection assay (lanes 1-5). An internal 3' labeled probe, as illustrated , was3
used. Positive control was Spg RNA from 16 day old 057 BL/10 mouse embryos (+). RNA
from these embryos produce two different protected fragments with the Avail probe (230
and 140 nucleotides) due to a single base pair mismatch with the probe used (see 10). RNA
from untransfected cells was used for negative control (-). Lane (M) is molecular weight
markers. Arrows point to the input fragment and the RNA protected probe fragment.
b) 30 pg samples of total cellular RNA from the same five Putko populatons as above was
analysed by Si nuclease protection assay (lanesl-5) using a I kb Hhal 5' labeled probe
(see Fig 5). Transcripts from a transient vector in which the expression of fiH was driven
by an SV40 enhancer produced a 120 bp protected fragment (lane a), while Spg RNA
from 16 day old 057 BL/10 mouse embryos produced a 75 bp protected fragment (+.
Untransfected Putko cells were used as negative control (-). Lane (M) is molecular weight
markers. Arrows points to the 51 protected fragment resulting from the hybridization of
probe to the complementary 5' end of mouse 112 RNA (+)
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Figure 7: Northern blot hybridization analysis of ,BH hybrid transcripts from expressing
Putko cells. The RNA blot was hybridized to a labeled mouse H2 Ava probe as illustrated
in Figure 6a. Lanes 1 and 2 are RNA from 107 Putko cells stably transfected with lH
hybrid gene. These two lanes correspond to lanes 3 and 4 in Figure Sa. Positive control
was poly A RNA from 5x107 CS7 BL/10 mouse embryo cells (+). This RNA was expected
to be 45 bp shorter than the hybrid PH RNA. Poly A RNA from 107 untransfected Putko
cells was used as negative control (-).
HhaI 5' labelled probe (see Fig 5). This probe detects 120bp of the fi-H2 transcript in HeLa
cells transiently expressing the gene from an SV40 enhancer. None of the cells expressing
,BH hybrid RNA showed visible protected fragment with this probe (Figure 6b). Similarly
RNA from ten independently transfected K562 populations did not show protection of this
probe. These results were confirmed using an independent 235 bp DdeI-DdeI probe . We
conclude that the level of transcripts with intact 5' ends is below 0.1 per cell, which is the
limit of detection by this method. To estimate the size of the expressed fiH hybrid RNA,
Northern blot analysis was performed. This revealed transcripts approximately lOObp
shorter than control H2 mRNA (Fig 7). The presence of intact fiH DNA in these cells was
confirmed by Southern hybridisation. These results are consistent with our finding that the
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complete P-globin gene introduced in Putko cells produces transcripts with shorter 5' ends
than expected. Thus deletion or exchange of ,8-globin sequences upstream of the CAAT
box and/or downstream of the translation initiation site does not improve transcription
from this promoter in an embryonic/fetal environment.
DISCUSSION
K562 and its derivative Putko cell line show characteristics of embryonic erythroid
cells since they preferentially express embryonic and fetal but not adult human globin
gene. Several reports have suggested complete absence of the adult globin protein or
mRNA in K562 cells (18,14). In contrast Mouse Erythroleukemic Cells preferentially
express the adult ,8-globin gene (20). These cells also express detectable levels of introduced
cloned -y and e globin genes. Transcription of the embryonic genes in MEL cells is clearly
inappropriate as it occurs mainly from a site 200 bp upstream of the major cap site
and reaches steady state levels several orders of magnitude less than that of the adult
gene transcripts (21). We had reported earlier the occurrence of aberrant transcripts
containing the 3' end of ,8-globin gene in transfected K562 cells (17). In this paper we have
shown that the 5' end of similar transcripts arising in Putko cells is shorter than expected
by approximately 40 bp. Furthermore a hybrid gene containing P globin promoter and
mouse H2 gene 3' sequences is transcribed from approximately 100 bp downstream of the
major cap site. Thus genes that are suppressed/not expressed in a developmental specific
manner are still capable of aberrant transcriptional activity when cloned and introduced
into cells representing the nonpermissive stage. Since we only detect abnormal expression
with introduced rather than endogenous genes we suggest that trans-regulation may not
be sufficient for efficient regulation of gene activity. It is possible that the sequential
expression of individual members of a gene family is more dependant on trans- than cis-
regulation. This may explain the low level expression of globin genes observed in erythroid
precursor cells during normal blood cell differentiation (22).
We have attempted to define mechanisms involved in trans-regulation of the ,B-globin
gene in the Putko/K562 environment. To this aim we replaced fl-globin sequences with
those of a constitutively expressed gene, that of the mouse H2 transplantation antigen. The
choice of sequences that are to replace the adult globin DNA is important. For example a-
globin downstream sequences interfere with 'induction' of transcription from the ,B-globin
promoter in differentiating MEL cells (11). This interference is not present in hybrid genes
containing ,B-globin promoter and mouse H2 coding sequences (10). Using such hybrid j3-
H2 constructs we have shown that adult specific 'inducible' sequences which had been
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previously localised downstream of the mRNA capping site (10) are not responsible or
sufficient for suppression of activity of the fi-globin gene in the embryonic/fetal erythroid
environment. The nature of aberrant transcripts arising from the /3-globin promoter allows
us to speculate on the mechanism of promoter inactivity. It is interesting that in both cases
of the complete #-globin gene and of the fl-H2 chimeras the detected transcripts appear
to have shorter 5' ends. However the site of initiation of transcription is probably further
downstream of the mRNA capping site in the hybrid than in the complete gene. One
possibility is that transcriptional factors bind to the inactive /3-globin promoter but are
prevented from recognising the major cap site. These factors then proceed to initiate
transcription from putative downstream sequences. This conclusion is supported by our
observation that sequences overlapping the constitutive promoter elements are responsible
for the inactivity of the p-globin gene.
The nature of grans-regulation involved in the differential expression of the globin
genes remains to be defined. Sequences downstream of the ,B-globin mRNA capping site
have been shown to be involved in the developmental specific regulation of this gene (10,11).
Our results suggest a similar role for the ,B-globin gene promoter. Clearly the major
mRNA capping site of this gene is not recognised in an embryonic/fetal environment. We
have shown that this is an inherent property of the isolated /3-globin promoter sequences.
Interestingly ,9-globin promoter elements that are required for constitutive expression of
this gene are also present in the promoters of the embryonic and fetal globin genes. Obvious
differences are duplication of the CCAAT motif in the -y and the CCA/TCACAT motif in
the ,B promoters (1). However neither of these duplications appear to play a role in the
developmental specific regulation of globin genes (22 and our results). Our results suggest
that differences in the sequences of promoters of globin genes within 77 bp spanning the
CCAAT motif to the translation initiation signal are at least in part responsible for the
developmental specific expression of the globin genes.
Acknowledgments
K.Khazaie was supported by a Medical Research Council (U.K.) Recombinant Tech-
nology training fellowship. F.Gounari was supported by a Greek government training
fellowship. We are grateful to Dr. Kristina Quade for the gift of cellular RNA from C57
BL/10 mouse embryos, and to Dr. Bjorn Vennstrom for allowing the completion of the
final stages of this work in his laboratory.
*To whom correspondence should be addressed. Present address: European Molecular Biology
Laboratory, Postfach 10.2209, 6900 Heidelberg, FRG
7211
Nucleic Acids Research
REFERENCES
1. Maniatis,T., Fritsch,E.F., Lauer,J. and Lawn,R.M. (1981) Ann. Rev. Genetics
14, 145- 178.
2. Chada,K., Magram,J., Raphael,K., Radice,G., Lacy, E. and Constantini,F. (1985)
Nature 314,377-380.
3. Townes,T.M., Lingrel,J.B., Chen,H.Y., Brinster,R.L. and Palmiter,R.D. (1985)
EMB30 J. 4,1715-1723.
4. Magram,J., Chada,K. and Constantini,F. (1985) Nature 315, 338-340.
5. Deisseroth,A. and Hendrick,D. (1978) Cell 15, 55-63.
6. Pyati,J., Kucherlapati,R.S. and Skoultchi,A.I. (1980) Proc. Natl. Acad. Sci.
USA 77,3435-3439.
7. Willing,M.C., Nienhuis,A.W. and Anderson,W.F. (1979) Nature 277, 534-538.
8. Charnay,P., Mellon,P. and Maniatis,T. (1985) Mol. Cell. Biol. 5, 1498-1151.
9. Marks,P.A. and Rifkind,R.A. (1978) Ann. Rev. Biochemistry 47, 419-426.
10. Wright,S., Rosenthal,A., Flavell,R. and Grosveld,F. (1984) Cell 38, 264-273.
11. Charnay,P., Treisman,R., Mellon,P., Chao,M., Axel,R. and Maniatis,T. (1984)
Cell 38, 251-263.
12. Lozzio,C.B. and Lozzio,B.B. (1975) Blood 45, 321-334.
13. Klein,G., Zeuthen,J., Eriksson,I., Tekasaki,P., Bernoco,M., Rosen,A., Masu-
cci,G., Povey,S. and Ber,R. (1980) Journal of the Natl. Cancer Institute 64,
725-738.
14. Rutherford,T., Clegg,J.B., Higgs,D.R., Jones,R.W., Thonipson,I. and Weather-
all,D.Y. (1981) Proc. Natl. Acad. Sci. USA 78, 348-352.
15. Charnay,P. and Maniatis,T. (1983) Science 220, 1281-1282.
16. Dean,A., Ley,T.J., Humphries,R.K., Fordis,M. and Schechter,A.M. (1983) Proc.
Natl. Acad. Sci. USA 80, 5515-5519.
17. Kiousis,D. Wilson,F., Khazaie,K. and Grosveld,F. (1985) EMBO J. 4, 927-931.
18. Young,L., Donova-Peluso,M., Cubbon,R. and Axel,R. (1985) Nucl. Ac. Res.
13, 5203-5213.
19. Grosveld,F.G., Lund,T., Murray,E.J., Mellon,A.L., Dahl,H.H. and Flavell,R.A.
(1982) Nucl. Ac. Res. 10, 6715-6732.
20. Wright,S., deBoer,E., Grosveld,F.G. and Flavell,R.A. (1983) Nature 305, 333-
335.
21. Allan,M., Montague,P., Joan,G., Sibbet,G., Donovan-Peluso,M. Bank,S. and
Paul,J. (1985) Nucl. Ac. Res. 13, 6125-6136.
22. Harrison,P.R., Conkie,D., Affara,N. and Paul,J. (1974) J.Cell Biol. 63, 402-413.
23. Anagou,N.P., Karlsson,S., Moulton,A.D., Keller,G. and Nienhuis,A.W. (1986)
EMBO J. 5, 121-126.
7212
